OPENCASE
LIVE

Serial Number

99733991

Owner

OpenEvidence Inc.

Attorney

Lisa Greenwald-Swire

Filing Date

Mar 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OPENCASE Trademark

Serial Number: 99733991

OPENCASE is a trademark filed by OpenEvidence Inc. on March 30, 2026. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

OpenEvidence Inc. (200 trademarks)

215 NW Street
Miami, FL 33127

Entity Type: 03

Trademark Details

Filing Date

March 30, 2026

Registration Date

Not Registered

Goods & Services

Providing medical information; Providing health information; Providing healthcare information; Providing health care information via a global computer network; Providing health information via a website; Providing a web site featuring medical information; Providing a web site featuring information on health and nutrition; Providing a website featuring information about health, wellness and nutrition; Providing an on-line computer database featuring information regarding health and nutrition; Providing medical information in the field of medicine, healthcare, pharmaceuticals, fitness, nutrition, dieting, and wellness; Providing health information in the field of medicine, healthcare, pharmaceuticals, fitness, nutrition, dieting, and wellness; Medical services, namely, medical consulting services rendered using artificial intelligence (AI) that delivers expert-level analysis on patient-specific cases as well as in-depth research and synthesis of user-specified domains within biomedical sciences for healthcare professionals and researchers; Medical services, namely, providing clinical data analysis for use by healthcare providers in connection with medical diagnosis and treatment; Medical services, namely, analyzing and providing clinical data to facilitate healthcare provider decision making for the diagnosis and treatment of persons; Health assessment services; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Medical analysis services relating to the treatment of patients

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 18, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 18, 2026 GNSL
SUSPENSION LETTER WRITTEN
Aug 18, 2026 CNSL
ASSIGNED TO EXAMINER
Aug 5, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 30, 2026 MAFR
NEW APPLICATION ENTERED
Mar 30, 2026 NWAP